• Why GPRD?
• Services and Products
• • Level 4
  • Pharmacovigilance
  • Drug Utilisation & Disease Patterns
  • Health Outcomes
  • Clinical
  • Level 3
  • Data Sets
  • Consulting
  • Verification Services
  • Price Plan
  • Build Your Own
• Academic Research
• Information for GPs
• ISAC
• Latest News
• Contact Us
• Vacancies

Services - Level 3

GPRD Level 3 gives users full access to core GPRD data (including all prescriptions and diagnosis records). Tools included with Level 3 licence gives the user freedom to create, modify and extend queries, enabling rapid reaction to research findings and further detailed analyses.

The tools included with Level 3 are:

Hierarchical reference dictionaries:
Clinical data are available as original Read Clinical Terms (as recorded by the GP) and are also mapped to the MedDRA Terminology. Prescription data are available with original Multilex drug/product names (as recorded by the GP) and are also mapped to the Anatomical Therapeutic Chemical (ATC) and British National Formulary (BNF) classification systems.

Daily dose:
Conversion factors to allow like-for-like comparisons to be made.

Data quality markers:
Indicates data quality at both patient and practice level.

Download our information sheet

Services - GPRD Risk Management Knowledge and Tracking

Risk Management- Regulatory requirements- The role of GPRD

The Risk Management plan now required by regulators for new products, dose/formulation changes, indication changes and emerging safety issues requires the collection of real world usage on the product and potentially comparators in the same class.

GPRD, the world’s largest, most validated, longitudinal observational dataset is an ideal vehicle in which to meet these regulatory requirements. Specifically there is a new service from the GPRD team that provides cubes of data tailored to your need. The service delivers highly detailed information to enable you to provide the required data to regulators, the data as specified in the products Risk Management Plan.

Additionally the new service also includes the provision of detailed real world information on the therapy area before launch (change to formulation, etc.) that is required for the Pharmacovigilance specification.

These two new services are called GPRD Risk Management Knowledge and Tracking and provide you with a range of options that will enable the following Tracking scenarios:

• Full launch with 6% of all UK tracking.
• Restricted GP monitored launch with 100% tracking (GP Sentinel)
• Hospital restricted diagnosis/starting drug with restricted GP prescribing- 100% tracking (Hospital/GP sentinel)

As the most granular of observational datasets GPRD can provide extraordinary depths of information that will ensure you can give the required detail in the Pharmacovigilance specification and enable a complete understanding of the real world patients in whom your drug is initially used.

The GPRD Risk Management Knowledge and Tracking service is available for your in-house staff to undertake the required work or on a full service basis with the work being done by the GPRD team.

Pricing is made on a case by case basis.

Please contact GPRD Helpdesk at admin@gprd.com for further information.